These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22733563)

  • 21. A pattern-mixture model for the analysis of censored quality-of-life data.
    Li H; Heitjan DF
    Stat Med; 2006 May; 25(9):1533-46. PubMed ID: 16435338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Bayesian meta-analytic approach for safety signal detection in randomized clinical trials.
    Odani M; Fukimbara S; Sato T
    Clin Trials; 2017 Apr; 14(2):192-200. PubMed ID: 28059578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modelling risk when binary outcomes are subject to error.
    McInturff P; Johnson WO; Cowling D; Gardner IA
    Stat Med; 2004 Apr; 23(7):1095-109. PubMed ID: 15057880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Part 1. Statistical Learning Methods for the Effects of Multiple Air Pollution Constituents.
    Coull BA; Bobb JF; Wellenius GA; Kioumourtzoglou MA; Mittleman MA; Koutrakis P; Godleski JJ
    Res Rep Health Eff Inst; 2015 Jun; (183 Pt 1-2):5-50. PubMed ID: 26333238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Bayesian missing data framework for generalized multiple outcome mixed treatment comparisons.
    Hong H; Chu H; Zhang J; Carlin BP
    Res Synth Methods; 2016 Mar; 7(1):6-22. PubMed ID: 26536149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous Bayesian adaptive randomization based on event times with covariates.
    Cheung YK; Inoue LY; Wathen JK; Thall PF
    Stat Med; 2006 Jan; 25(1):55-70. PubMed ID: 16025549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bayesian methods for cluster randomized trials with continuous responses.
    Spiegelhalter DJ
    Stat Med; 2001 Feb; 20(3):435-52. PubMed ID: 11180312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Semiparametric Bayesian analysis of accelerated failure time models with cluster structures.
    Li Z; Xu X; Shen J
    Stat Med; 2017 Nov; 36(25):3976-3989. PubMed ID: 28744875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bayesian enrichment strategies for randomized discontinuation trials.
    Trippa L; Rosner GL; Müller P
    Biometrics; 2012 Mar; 68(1):203-11. PubMed ID: 21714780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of Bayesian analyses to doubly randomized delayed start, matched control designs to demonstrate disease modification.
    Turkoz I; Sobel M; Alphs L
    Pharm Stat; 2019 Jan; 18(1):22-38. PubMed ID: 30221459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bayesian methods including nonrandomized study data increased the efficiency of postlaunch RCTs.
    Schmidt AF; Klugkist I; Klungel OH; Nielen M; de Boer A; Hoes AW; Groenwold RH
    J Clin Epidemiol; 2015 Apr; 68(4):387-96. PubMed ID: 25554520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Borrowing strength from external trials in a meta-analysis.
    Higgins JP; Whitehead A
    Stat Med; 1996 Dec; 15(24):2733-49. PubMed ID: 8981683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bayesian inference for randomized clinical trials with treatment failures.
    Shaffer ML; Chinchilli VM
    Stat Med; 2004 Apr; 23(8):1215-28. PubMed ID: 15083479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting event times in clinical trials when treatment arm is masked.
    Donovan JM; Elliott MR; Heitjan DF
    J Biopharm Stat; 2006 May; 16(3):343-56. PubMed ID: 16724489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new Bayesian joint model for longitudinal count data with many zeros, intermittent missingness, and dropout with applications to HIV prevention trials.
    Wu J; Chen MH; Schifano ED; Ibrahim JG; Fisher JD
    Stat Med; 2019 Dec; 38(30):5565-5586. PubMed ID: 31691322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bayesian analysis for generalized linear models with nonignorably missing covariates.
    Huang L; Chen MH; Ibrahim JG
    Biometrics; 2005 Sep; 61(3):767-80. PubMed ID: 16135028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Bayesian goodness of fit test and semiparametric generalization of logistic regression with measurement data.
    Schörgendorfer A; Branscum AJ; Hanson TE
    Biometrics; 2013 Jun; 69(2):508-19. PubMed ID: 23489010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Semiparametric Bayesian analysis of censored linear regression with errors-in-covariates.
    Sinha S; Wang S
    Stat Methods Med Res; 2017 Jun; 26(3):1389-1415. PubMed ID: 25882297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bayesian methods for analysis of binary outcome data in cluster randomized trials on the absolute risk scale.
    Thompson SG; Warn DE; Turner RM
    Stat Med; 2004 Feb; 23(3):389-410. PubMed ID: 14748035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of informative priors skeptical of large treatment effects in clinical trials: A simulation study.
    Pedroza C; Han W; Truong VTT; Green C; Tyson JE
    Stat Methods Med Res; 2018 Jan; 27(1):79-96. PubMed ID: 26668090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.